Jefferies Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,000
| Closed | -$491K | – | 1618 |
|
|
2022
Q1 | $491K | Sell |
1,000
-4,600
| -82% | -$2.1M | ﹤0.01% | 1060 |
|
|
2021
Q4 | $2.6M | Sell |
5,600
-49,595
| -90% | -$20.9M | 0.02% | 705 |
|
|
2021
Q3 | $20.6M | Buy |
55,195
+5,427
| +11% | +$2.06M | 0.15% | 121 |
|
|
2021
Q2 | $19M | Buy |
49,768
+3,292
| +7% | +$1.26M | 0.12% | 133 |
|
|
2021
Q1 | $16.7M | Sell |
46,476
-16,630
| -26% | -$5.35M | 0.15% | 106 |
|
|
2020
Q4 | $20.3M | Buy |
63,106
+56,606
| +871% | +$17.4M | 0.16% | 104 |
|
|
2020
Q3 | $1.75M | Sell |
6,500
-61
| -0.9% | -$16.4K | 0.02% | 621 |
|
|
2020
Q2 | $1.73K | Buy |
6,561
+6,122
| +1,395% | +$1.63M | 0.02% | 607 |
|
|
2020
Q1 | $101K | Buy |
+439
| New | +$120K | ﹤0.01% | 1786 |
|
|
2019
Q4 | – | Sell |
-36,422
| Closed | -$10M | – | 2655 |
|
|
2019
Q3 | $8.74M | Buy |
36,422
+20,380
| +127% | +$5.58M | 0.07% | 272 |
|
|
2019
Q2 | $4.53M | Sell |
16,042
-29,121
| -64% | -$7.95M | 0.03% | 521 |
|
|
2019
Q1 | $13M | Buy |
45,163
+37,687
| +504% | +$10.9M | 0.11% | 154 |
|
|
2018
Q4 | $1.96M | Buy |
7,476
+275
| +4% | +$75.6K | 0.02% | 835 |
|
|
2018
Q3 | $1.97M | Sell |
7,201
-2,506
| -26% | -$651K | 0.01% | 984 |
|
|
2018
Q2 | $2.31M | Buy |
9,707
+5,173
| +114% | +$1.2M | 0.01% | 826 |
|
|
2018
Q1 | $996K | Sell |
4,534
-2,034
| -31% | -$478K | 0.01% | 1196 |
|
|
2017
Q4 | $1.48M | Sell |
6,568
-1,588
| -19% | -$338K | 0.01% | 1137 |
|
|
2017
Q3 | $1.55M | Sell |
8,156
-16,374
| -67% | -$3.12M | 0.01% | 1070 |
|
|
2017
Q2 | $4.62M | Buy |
24,530
+14,100
| +135% | +$2.53M | 0.03% | 567 |
|
|
2017
Q1 | $1.73M | Buy |
10,430
+10,108
| +3,139% | +$1.61M | 0.01% | 1001 |
|
|
2016
Q4 | $46K | Sell |
322
-1,120
| -78% | -$150K | ﹤0.01% | 2087 |
|
|
2016
Q3 | $181K | Sell |
1,442
-38,822
| -96% | -$5.01M | ﹤0.01% | 1969 |
|
|
2016
Q2 | $5.29M | Buy |
40,264
+10,476
| +35% | +$1.43M | 0.02% | 483 |
|
|
2016
Q1 | $4.14M | Buy |
29,788
+20,995
| +239% | +$2.81M | 0.02% | 550 |
|
|
2015
Q4 | $1.23M | Sell |
8,793
-3,420
| -28% | -$471K | 0.01% | 1087 |
|
|
2015
Q3 | $1.71M | Buy |
12,213
+8,815
| +259% | +$1.32M | 0.01% | 968 |
|
|
2015
Q2 | $558K | Buy |
3,398
+2,606
| +329% | +$416K | ﹤0.01% | 1518 |
|
|
2015
Q1 | $122K | Sell |
792
-32,704
| -98% | -$4.66M | ﹤0.01% | 1844 |
|
|
2014
Q4 | $4.21M | Sell |
33,496
-61,215
| -65% | -$7.56M | 0.02% | 475 |
|
|
2014
Q3 | $11.3M | Buy |
94,711
+91,231
| +2,622% | +$10.5M | 0.08% | 219 |
|
|
2014
Q2 | $374K | Sell |
3,480
-1,442
| -29% | -$149K | ﹤0.01% | 1401 |
|
|
2014
Q1 | $490K | Sell |
4,922
-1,904
| -28% | -$172K | ﹤0.01% | 1278 |
|
|
2013
Q4 | $631K | Sell |
6,826
-22,333
| -77% | -$1.98M | ﹤0.01% | 1039 |
|
|
2013
Q3 | $2.44M | Buy |
29,159
+13,683
| +88% | +$1.17M | 0.02% | 536 |
|
|
2013
Q2 | $1.27M | Buy |
+15,476
| New | +$1.16M | 0.01% | 682 |
|
Other funds holding ELV
Jefferies Group's ELV Position: Q2 2022 in Review
Jefferies Group sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 1,000 shares — an estimated $491K sold.
Jefferies Group first reported a position in ELV in Q2 2013 and held it in 35 quarters. The position peaked at $20.6M in Q3 2021. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.
- Jefferies Group reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
- Jefferies Group sold 1,000 Elevance Health shares in Q2 2022, an estimated $491K.
- Jefferies Group first reported a position in Elevance Health in Q2 2013 and held it in 35 quarters.
- Jefferies Group's Elevance Health position peaked at $20.6M in Q3 2021.
- 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.
Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.